Combining Automated Organoid Workflows with Artificial Intelligence-Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High-Throughput Screens for Parkinson's Disease and Beyond.

Renner, Henrik; Schöler, Hans R; Bruder, Jan M

Renner, Henrik; Schöler, Hans R; Bruder, Jan M.

Afiliação

Renner H; Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Schöler HR; Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Bruder JM; Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.

Mov Disord ; 36(12): 2745-2762, 2021 12.

Article em En | MEDLINE | ID: mdl-34498298

Assuntos

Doenças Neurodegenerativas; Doença de Parkinson; Animais; Inteligência Artificial; Doenças Neurodegenerativas/metabolismo; Organoides/metabolismo; Doença de Parkinson/tratamento farmacológico; Fluxo de Trabalho

Palavras-chave

Parkinson's disease; artificial intelligence; drug development; high-throughput screening; machine learning; midbrain; organoids

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Doenças Neurodegenerativas Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google